208 related articles for article (PubMed ID: 9424766)
1. [The pathogenesis and therapy of hemostatic disorders in cancer patients].
Barkagan ZS
Ter Arkh; 1997; 69(7):65-7. PubMed ID: 9424766
[No Abstract] [Full Text] [Related]
2. [Cancer, hemostasis and coaguloactive drugs].
Nadiradze ISh
Vopr Onkol; 1989; 35(12):1411-8. PubMed ID: 2692281
[No Abstract] [Full Text] [Related]
3. [Thrombosis and cancer. An update of our knowledge].
Tumori; 2006; 92(5):23-41. PubMed ID: 17168451
[No Abstract] [Full Text] [Related]
4. Hemostasis and thrombosis in critically ill children.
Kenet G; Strauss T; Kaplinsky C; Paret G
Semin Thromb Hemost; 2008 Jul; 34(5):451-8. PubMed ID: 18956285
[TBL] [Abstract][Full Text] [Related]
5. [The pathogenesis and treatment of the hemostatic disorder in acute promyelocytic leukemia].
Velasco F; López-Pedrera R; Páramo JA
Med Clin (Barc); 1996 Jun; 107(2):59-61. PubMed ID: 8753897
[No Abstract] [Full Text] [Related]
6. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.
Antovic A
Semin Thromb Hemost; 2010 Oct; 36(7):772-9. PubMed ID: 20978998
[TBL] [Abstract][Full Text] [Related]
7. Acute thrombotic disorders.
Kuntz JG; Cheesman JD; Powers RD
Am J Emerg Med; 2006 Jul; 24(4):460-7. PubMed ID: 16787806
[TBL] [Abstract][Full Text] [Related]
8. [Disorders of the hemostatic system in patients with disseminated stomach cancer].
Tiutrin II; Karpov AB; Udut VV; Tsisik RM; Solokhina EA
Vopr Onkol; 1989; 35(4):460-5. PubMed ID: 2728389
[TBL] [Abstract][Full Text] [Related]
9. [The pathology of hemostasis].
Makarov VA
Patol Fiziol Eksp Ter; 1998; (4):40-8. PubMed ID: 9951305
[No Abstract] [Full Text] [Related]
10. Coagulation and cancer: biological and clinical aspects.
Falanga A; Marchetti M; Vignoli A
J Thromb Haemost; 2013 Feb; 11(2):223-33. PubMed ID: 23279708
[TBL] [Abstract][Full Text] [Related]
11. [Anticoagulant drugs. Fibrinolytic drugs].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):105-7. PubMed ID: 133400
[No Abstract] [Full Text] [Related]
12. Thrombosis in childhood cancer.
Allen GA; Bhat R
Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
[No Abstract] [Full Text] [Related]
13. Clinical implications of laboratory testing for the thrombophilic disorders.
Kirkland MA; Gallus AS
Aust N Z J Med; 1993 Jun; 23(3):291-302. PubMed ID: 8352706
[No Abstract] [Full Text] [Related]
14. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
15. [An antithrombotic therapy from the viewpoint of hematology].
Asakura H
Brain Nerve; 2015 Jan; 67(1):83-91. PubMed ID: 25585437
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated thrombosis: the when, how and why.
Fernandes CJ; Morinaga LTK; Alves JL; Castro MA; Calderaro D; Jardim CVP; Souza R
Eur Respir Rev; 2019 Mar; 28(151):. PubMed ID: 30918022
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Assessment of Hemostatic and Anticoagulant Therapy.
Adcock DM; Gosselin RC
Semin Thromb Hemost; 2017 Apr; 43(3):242-244. PubMed ID: 28346961
[No Abstract] [Full Text] [Related]
18. The role of hemostatic system inhibitors in malignancy.
Wojtukiewicz MZ; Sierko E; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):621-42. PubMed ID: 18000789
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis and Hemostasis Issues in Cancer - Second International Conference. 19-21 September, 2003, Bergamo, Italy.
Zacharski LR
IDrugs; 2003 Nov; 6(11):1036-8. PubMed ID: 15270033
[No Abstract] [Full Text] [Related]
20. Thrombosis: the relationship of hemostatic mechanisms to drug therapy.
Wessler S; Gitel SN
J Neurosurg; 1981 Jan; 54(1):1-11. PubMed ID: 7007586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
